Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 3/20 | 0.57 |
| ▸ | TK2 | O00142 | 4/20 | 0.53 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.50 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.49 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.49 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.49 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14853756 | 1.00 | PYGM (0.57) | PYGMTK2P2RY6SLC28A1SLC28A2 | |
| SCHEMBL14930959 | 1.00 | PYGM (0.57) | PYGMTK2P2RY6SLC28A1SLC28A2 | |
| SCHEMBL14842287 | 1.00 | PYGM (0.57) | PYGMTK2P2RY6SLC28A1SLC28A2 | |
| SCHEMBL14929088 | 1.00 | PYGM (0.57) | PYGMTK2P2RY6SLC28A1SLC28A2 | |
| SCHEMBL442314 | 0.96 | PYGM (0.53) | PYGMTK2P2RY6SLC28A1SLC28A2 | |
| SCHEMBL18161337 | 0.92 | PYGM (0.55) | PYGMTK2P2RY6SLC28A1SLC28A2 | |
| SCHEMBL18158974 | 0.92 | PYGM (0.55) | PYGMTK2P2RY6SLC28A1SLC28A2 | |
| SCHEMBL26370054 | 0.91 | PYGM (0.47) | PYGMTK2P2RY6 | |
| SCHEMBL29634965 | 0.91 | TK2 (0.52) | PYGMTK2 | |
| SCHEMBL18512878 | 0.88 | PYGM (0.61) | PYGMTK2P2RY6SLC28A1SLC28A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 731 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705468-A1 | MAMMALIAN POLYCISTRONIC EXPRESSION SYSTEM FOR DIRECT TRANSLATION FROM RNA AND SECRETION OF CARGO | California Institute of Technology (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024229296-A1 | MAMMALIAN POLYCISTRONIC EXPRESSION SYSTEM FOR DIRECT TRANSLATION FROM RNA AND SECRETION OF CARGO | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2024-11-07 | — | — | WO | claimed |
| WO-2023217209-A1 | DOUBLE-STRANDED RNA MOLECULE AND PHARMACEUTICAL USE THEREOF | 澳门科技大学 | 2023-11-16 | — | — | WO | claimed |
| US-10441653-B2 | Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant | CUREVAC AG (DE) | 2019-10-15 | — | — | US | claimed |
| EP-3394327-A1 | DNA-ENCODED CHEMICAL LIBRARY, USE THEREOF AND METHOD TO SYNTHESIZE THE LIBRARY | Technische Universität Dortmund (DE) | 2018-10-31 | — | — | EP | claimed |
| WO-2017108741-A1 | DNA-ENCODED CHEMICAL LIBRARY, USE THEREOF AND METHOD TO SYNTHESIZE THE LIBRARY | TECHNISCHE UNIVERSITÄT DORTMUND (DE) | 2017-06-29 | — | — | WO | claimed |
| EP-3184674-A1 | DNA-ENCODED CHEMICAL LIBRARY, USE THEREOF AND METHOD TO SYNTHESIZE THE LIBRARY | Technische Universität Dortmund (DE) | 2017-06-28 | — | — | EP | claimed |
| EP-0795029-A1 | CHEMICAL LABELLING OF OBJECTS | Pabio (NO) | 1997-09-17 | — | — | EP | claimed |
| WO-1996017954-A1 | CHEMICAL LABELLING OF OBJECTS | PABIO (DK) | 1996-06-13 | — | — | WO | claimed |
| US-12637672-B2 | Oligonucleotide compositions and methods thereof | WAVE LIFE SCIENCES LTD. (SG) | 2026-05-26 | — | — | US | disclosed |
| WO-2026102473-A1 | TEMPERATURE DEPENDENT PROBES FOR TARGET DETECTION | SPEEDX PTY LTD (AU) | 2026-05-21 | — | — | WO | disclosed |
| EP-3827390-B1 | SYSTEMS AND METHODS FOR SUPPORTING MULTIPLE AUTOMATED WORKFLOWS | LIFEFOUNDRY INC (US) | 2026-05-20 | — | — | EP | disclosed |
| CN-122031506-A | Chiral control | 波涛生命科学有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4731186-A2 | METHODS AND COMPOSITIONS FOR TREATING EPITHELIAL DISEASES | The Regents of the University of California (US) | 2026-04-29 | — | — | EP | disclosed |
| WO-2000026226-A1 | MULTIDOMAIN POLYNUCLEOTIDE MOLECULAR SENSORS | YALE UNIVERSITY (US) | 2000-05-11 | — | — | WO | disclosed |
| EP-0795029-A1 | CHEMICAL LABELLING OF OBJECTS | Pabio (NO) | 1997-09-17 | — | — | EP | disclosed |
| WO-1996017954-A1 | CHEMICAL LABELLING OF OBJECTS | PABIO (DK) | 1996-06-13 | — | — | WO | disclosed |
| EP-0311694-B1 | NUCLEOSIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | RIKAGAKU KENKYUSHO (JP) | 1995-12-13 | — | — | EP | disclosed |
| US-5144018-A | Antiviral Agents | RIKAGAKU KENKYUSHO (JP) | 1992-09-01 | — | — | US | disclosed |
| EP-0311694-A1 | NUCLEOSIDE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | RIKAGAKU KENKYUSHO (JP) | 1989-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637672-B2 | Oligonucleotide compositions and methods thereof | UPF1, SMN1; SMN2, RNGTT | PYGM 15/4885TK2 313/4885P2RY6 362/4885 |
| US-10441653-B2 | Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvant | TLR9, TLR7, GMNN | PYGM 983/4885TK2 1245/4885P2RY6 288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.